参考文献/References:
[1] ARBER D A, ORAZI A, HASSERJIAN R, et al.The 2016 revision to the World Health Organizationclassification of myeloid neoplasms and acuteleukemia[J]. Blood, 2016, 127(20): 2391-2405.
[2] DE BRAEKELEER E, DOUET-GUILBERT N, DEBRAEKELEER M. RARA fusion genes in acutepromyelocytic leukemia: a review[J]. Expert Review ofHematology, 2014, 7(3): 347-357.
[3] WANG Xinrui, FAN Huiyong, XU Congling, et al.KDM3B suppresses APL progression by restrictingchromatin accessibility and facilitating the ATRAmediateddegradation of PML/RARα[J] .Cancer CellInternational, 2019,19(1): 256.
[4] YE Jing, ZHA Jie, SHI Yuanfei, et al. Co-inhibitionof HDAC and MLL-menin interaction targets MLLrearrangedacute myeloid leukemia cells via disruptionof DNA damage checkpoint and DNA repair[J].Clinical Epigenetics, 2019, 11(1): 137.
[5] TOMLINSON B, LAZARUS H M. Enhancing acutemyeloid leukemia therapy - monitoring responseusing residual disease testing as a guide to therapeuticdecision-making[J]. Expert Review of Hematology,2017, 10(6): 563-574.
[6] TONG Yongqing, ZHAO Zhijun, LIU Bei, et al. Newrapid method to detect BCR-ABL fusion genes withmultiplex RT-qPCR in one-tube at a time[J]. LeukemiaResearch, 2018, 69: 47-53.
[7] WANG Ziwei, GUO Mengqiao, ZHANG Yuesheng, etal. The applicability of multiparameter flow cytometryfor the detection of minimal residual disease usingdifferent-from-normal panels to predict relapse inpatients with acute myeloidleukemia after allogeneictransplantation[J]. International Journal of LaboratoryHematology, 2019, 41(5): 607-614.
[8] HRABOVSKY S, FOLBER F, HORACEK J M, etal. Comparison of real-time quantitative polymerasechain reaction and eight-color flow cytometry inassessment of minimal residual disease in adult acutelymphoblastic leukemia[J]. Clinical LymphomaMyeloma & Leukemia, 2018, 18(11): 743-748.
[9] 张坤龙，王宁玲，徐修才，等．多重RT-PCR 检测儿童急性淋巴细胞白血病融合基因的临床研究[J]．中国小儿血液与肿瘤杂志，2014，19（5）：233-237． ZHANG Kunlong，WANG Ningling，XU Xiucai,et al. The clinical study on fusion genes in childhoodacute lymphoblastic leukemia by multiplex ;RT-PCR[J]．Journal of China Pediatric Blood and Cancer，2014,19（5）：233-237．
[10] L VVIK JUUL-DAM K,GULDBORG NYVOLD C, VALERHAUGEN H, et al.Measurable residual diseasemonitoring using Wilms tumor gene 1 expression inchildhood acute myeloid leukemia based on childspecificreference values[J]．Pediatr Blood Cancer，2019 ，66(6):e27671.
[11] SELIM A G, MOORE A S. Molecular minimalresidual disease monitoring in acute myeloid leukemiachallenges and future directions[J]. Journal ofMolecular Diagnostics, 2018, 20(4): 389-397.
[12] SINGH M, BHATIA P, TREHAN A，et al. High frequencyof intermediate and poor risk copy numberabnormalities in pediatric cohort of B-ALL correlatewith high MRD post induction. [J]. Leuk Res，2018 ，66:79-84.
相似文献/References:
[1]苗玉迪a,魏绪仓b.达沙替尼联合氟达拉滨对慢粒K562细胞的抑制作用研究[J].现代检验医学杂志,2015,30(05):70.[doi:10.3969/j.issn.1671-7414.2015.05.021]
MIAO Yu-dia,WEI Xu-cangb.Study on Inhibition of Dasatinib and Fludarabine to CML K562 Cells[J].Journal of Modern Laboratory Medicine,2015,30(02):70.[doi:10.3969/j.issn.1671-7414.2015.05.021]
[2]姚亚洲,郑引索.72例老年急性白血病免疫表型分析[J].现代检验医学杂志,2015,30(05):91.[doi:10.3969/j.issn.1671-7414.2015.05.027]
YAO Ya-zhou,ZHENG Yin-suo.Immunophenotype Analysis of 72 Cases of Elderly Acute Leukemia[J].Journal of Modern Laboratory Medicine,2015,30(02):91.[doi:10.3969/j.issn.1671-7414.2015.05.027]
[3]王结珍,梁培松,王伟佳,等.血清PCT,IL-6和CRP水平检测对白血病患者化疗并发败血症的诊断价值[J].现代检验医学杂志,2019,34(02):88.[doi:10.3969/j.issn.1671-7414.2019.02.023]
WANG Jie-zhen,LIANG Pei-song,WANG Wei-jia,et al.Diagnostic Value of Serum PCT,IL-6 and CRPin Septicemia Patients with Leukemia in Chemotherapy[J].Journal of Modern Laboratory Medicine,2019,34(02):88.[doi:10.3969/j.issn.1671-7414.2019.02.023]
[4]张志远,郑 直,田晓怡.融合基因检测方法的最新研究进展[J].现代检验医学杂志,2024,39(05):205.[doi:10.3969/j.issn.1671-7414.2024.05.038]
ZHANG Zhiyuan,ZHENG Zhi,TIAN Xiaoyi.Advancements in Latest Fusion Gene Detection Methods: A Comprehensive Review[J].Journal of Modern Laboratory Medicine,2024,39(02):205.[doi:10.3969/j.issn.1671-7414.2024.05.038]
[5]付朝泓,李艳,童永清,等.BCR-ABL融合基因核酸检测试剂的研发及临床应用[J].现代检验医学杂志,2015,30(06):52.[doi:10.3969/j.issn.1671-7414.2015.06.015]
FU Chao-hong,LI Yan,TONG Yong-qing,et al.Development and Clinical Application of A Novel Nucleic
Acid Detection Reagent for BCR-ABL Fusion Gene[J].Journal of Modern Laboratory Medicine,2015,30(02):52.[doi:10.3969/j.issn.1671-7414.2015.06.015]